Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B-Reference-Cited by-同舟云学术

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Published:2017-06-25 Issue:2 Volume:23 Page:170-178
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Sohn Won,Cho Ju-Yeon,Kim Ji Hoon,Lee Jung Il,Kim Hyung Joon,Woo Min-Ah,Jung Sin-Ho,Paik Yong-Han

Funder

The Korean Association for the Study of the Liver

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://www.e-cmh.org/upload/pdf/cmh-2016-0086.pdf

Reference26 articles.

1. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

2. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

3. AASLD guidelines for treatment of chronic hepatitis B

4. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

5. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection;Journal of Medical Virology;2024-08-29

2. Disease modifiers and novel markers in HBV-related HCC;Journal of Liver Cancer;2024-08-05

3. Applicability of Risk Scores to an Indian Cohort of Hepatitis B-Related Hepatocellular Carcinoma Patients;Journal of Clinical and Experimental Hepatology;2024-07

4. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease;Journal of Gastroenterology and Hepatology;2024-07

5. Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy;Cancers;2024-02-22